$CRL· SEC filing ·

CRL Reports $994.2M Q4 Rev, $(5.62) GAAP EPS, $2.39 Non-GAAP EPS, $4.02B FY Rev, $10.28 Non-GAAP EPS, $50B 2026 Guidance

Charles River Laboratories International, Inc. · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · Now $182.07

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS